SC
Steven Cohen (Point72) disclosed increased in TENAX THERAPEUTICS INC
Steven Cohen (Point72) filed a 13F change in TENAX THERAPEUTICS INC (88032L605) on 2026-05-15, covering period end 2026-03-31.
Action
Increased
Capital
$3,376,671 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.